Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
Open Access
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (10) , 655-668
- https://doi.org/10.1016/j.bbmt.2004.07.007
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialBlood, 2004
- Tumor necrosis factor-α blockade for the treatment of acute GVHDBlood, 2004
- Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantationClinical Transplantation, 2001
- Two tumour necrosis factor receptors: structure and functionPublished by Elsevier ,2000
- InfliximabDrugs, 2000
- Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesionsJournal of the American Academy of Dermatology, 2000
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- MYCOPHENOLATE MOFETIL AND CYCLOSPORINE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BLOOD STEM CELL TRANSPLANTATIONTransplantation, 1999
- Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivoClinical and Experimental Immunology, 1992